crown

Subscribe Now

FOLLOW US

Sign in

bharat biotech

PAGE 2

Holds promise: ICMR on trial results of third dose of Covaxin

Updated on Jan 9, 2022 17:20 IST

Prime Minister Narendra Modi, in a televised address on December 25, 2021, announced precaution doses for healthcare and frontline workers from January 10 and Covid-19 jabs for the teenagers aged 15-18 years.

Trials show Covaxin safe for booster dose, says Bharat Biotech

Reactogenicity after vaccine and placebo was minimal and comparable, and no serious adverse events were reported, the company said referring to the trial results.

Updated on Jan 8, 2022 16:14 IST

No painkiller recommended for children vaccinated with Covaxin: Bharat Biotech

India opened up vaccination with Covaxin for children aged 15-18 after the company received approval from the Drug Controller General of India (DCGI).

Published on Jan 5, 2022 13:15 IST

Centre rejects reports of expired vaccines being administered as ‘misleading’

Bharat Biotech's Covaxin vaccine is the only vaccine with emergency use listing for the 15-18 age group in India.

Published on Jan 3, 2022 11:15 IST

Covaxin safe, immunogenic in 2-18 age group: Bharat Biotech

Bharat Biotech on Thursday said that its vaccine was found to be ‘safe, well-tolerated, and immunogenic’ in phase 2/3 clinical trials on children in the 2-18 years age group.

Updated on Dec 30, 2021 23:20 IST

Vaccination for 15-18 years: Only Covaxin likely to be administered

Covaxin has got the nod from the DCGI for emergency use on children on December 25.

Published on Dec 26, 2021 17:31 IST

News updates from HT: PM Modi stresses importance of ties with C Asian nations

Prime Minister Narendra Modi with foreign ministers of Kazakhstan, Kyrgyz Republic, Tajikistan, Turkmenistan and Uzbekistan.

Published on Dec 20, 2021 15:26 IST

Opened vials of Covaxin can be stored for up to 28 days: Bharat Biotech

Bharat Biotech said the multidose vial policy would save money for procurement agencies by reducing cold chain logistics.

Published on Dec 20, 2021 15:14 IST

Bharat Biotech seeks trial for intranasal Covid-19 vaccine booster

Covaxin, the company's Covid-19 vaccine already approved for emergency-use approval in the county, is administered through an injection.

Published on Dec 20, 2021 13:19 IST

Additional information sought: MoS health informs Parliament on Covaxin for kids

Bharat Biotech's Covaxin received the emergency use listing (EUL) from the World Health Organisation (WHO) on November 3.

Updated on Nov 30, 2021 16:42 IST

‘An evidence of effectiveness’: Bharat Biotech on real-world study of Covaxin

Image used only for representative purpose (PTI)

Published on Nov 25, 2021 03:56 IST

Covaxin 50% effective against Delta variant: Real-world study

Covaxin in clinical trials had an estimated efficacy of 65% when the more infectious Delta variant was taken into account. (Agencies)

Updated on Nov 25, 2021 24:45 IST

How ‘monkey business’ for Covaxin trial was accomplished near Nagpur

The National Institute of Virology (NIV) researchers contacted multiple zoos and institutes all over India to find some without any luck.

Published on Nov 14, 2021 14:15 IST

News updates from HT: BSF fatally shoots 2 alleged Bangladeshi cattle smugglers

BSF guards at the Indo-Bangladesh border in Nadia, West Bengal (File Photo)

Published on Nov 12, 2021 07:23 IST

Lancet publication marks safety and efficacy of Covaxin, says Bharat Biotech

Bharat Biotech's Covaxin (Sanchit Khanna/HT PHOTO)

Published on Nov 12, 2021 05:35 IST

Wait for Covaxin's Covid-19 jab for children gets longer

Bharat Biotech said in an official statement earlier that they are waiting for further approvals from the drug regulators.

Published on Nov 8, 2021 13:44 IST

Covaxin approval requested in US for ages 2-18 by Bharat Biotech's partner

Covaxin, developed in India by Bharat Biotech, gained emergency approval from the World Health Organization last week.

Published on Nov 6, 2021 04:07 IST

After WHO nod, travellers vaccinated with Covaxin allowed to enter US from Nov 8

The World Health Organization gave emergency use listing to Covaxin on Wednesday.

Published on Nov 4, 2021 02:27 IST

Momentous occasion for Indian science: Bharat Biotech MD on WHO nod of Covaxin

Bharat Biotech chairman and managing director Krishna Ella also thanked Union health minister Mansukh Mandaviya and all officials of the ministry for their “hardwork” after Covaxin received the WHO nod for emergency use.

Published on Nov 3, 2021 18:34 IST

'Diwali of Aatmanirbhar Bharat': Health minister hails PM for Covaxin's WHO nod

Bharat Biotech's Covaxin becomes India's first indigenous Covid-19 vaccine to get WHO approval.

Published on Nov 3, 2021 13:23 IST

Covaxin gets WHO approval for emergency use listing

Bharat Biotech's Covaxin in now a WHO-approved vaccine against Covid-19.

Published on Nov 3, 2021 11:42 IST

Covaxin's shelf life extended to 12 months, announces Bharat Biotech

Bharat Biotech said the stakeholders have been informed about the announcement that now Covaxin doses are good for use till one year from the date of manufacture.

Published on Nov 3, 2021 11:06 IST

Guyana recognises Covaxin; Indian high commission hails ‘important step’

Vials of Bharat Biotech's Covaxin Covid-19 vaccine (HT File Photo)

Published on Nov 2, 2021 06:53 IST

News updates from HT: Australia to recognise Covaxin and all the latest news

Covaxin (File Photo)

Published on Nov 1, 2021 07:27 IST

US firm eyes trials for Bharat Biotech’s Covaxin but delay in EUL a concern

Earlier, a decision on Covaxin EUL was expected on October 5, after WHO representatives sought additional information on September 27. (HT PHOTO)

Updated on Oct 29, 2021 21:05 IST

‘Centre following discussions in WHO’: Foreign secy Shringla on nod for Covaxin

Bharat Biotech's Covaxin (File Photo)

Published on Oct 28, 2021 12:26 IST

Oman adds Covaxin to approved list of Covid-19 vaccines

Covaxin (File Photo)

Published on Oct 27, 2021 13:27 IST

Covaxin may get approval within 24 hours, says WHO official

Covaxin manufacturer Bharat Biotech submitted data for the emergency use approval in April.

Published on Oct 26, 2021 10:46 IST

WHO to consider Covaxin's emergency listing in meet today

A health worker prepares a dose of the Covaxin Covid-19 vaccine at a vaccination center set up at a Delhi government health dispensary in New Delhi, India.

Published on Oct 26, 2021 24:01 IST

‘Phase 2 trials almost completed’: Dr Krishna Ella on nasal Covid-19 vaccine

A health worker collects swab samples for Covid-19 tests in Nagpur, Maharashtra. (PTI)

Published on Oct 23, 2021 10:36 IST

1
2

Home / India News / Bharat biotech

© 2026 HindustanTimes